Mephedrone (Meow, 4-Methylmethcathinone): examining the effects of a novel party drug on brain and behaviour

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Mephedrone ("Meow") is a novel recreational drug that has rapidly increased in popularity in recent years. Users report that mephedrone has the stimulant-like qualities of cocaine, combined with the prosocial effects of MDMA. Anecdotal and case study reports indicate that mephedrone may have the potential to engender compulsive patterns of use as well as toxicity in overdose. The current project will use animal models to assess how mephedrone affects the brain and behaviour and to assess its addictive potential.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $399,796.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biological Psychology (Neuropsychology, Psychopharmacology, Physiological Psychology)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

addiction | adolescent health | amphetamine | dopamine | psychopharmacology